BIODELIVERY SCIENCES INTERNATIONAL INC Intellectual Property Contracts & Agreements
17 Contracts & Agreements
- License Agreements (17 contracts)
- License Agreement, by and between the Company and Shionogi, dated as of April 4, 2019 (Filed With SEC on April 10, 2019)
- License Agreement dated July 12, 2017 by and between the Company, Arius and Purdue Pharma (Filed With SEC on November 9, 2017)
- FOIA CONFIDENTIAL TREATMENT REQUEST BY BIODELIVERY SCIENCES INTERNATIONAL, INC. IRS EMPLOYER IDENTIFICATION NUMBER 35-2089858 CONFIDENTIAL TREATMENT REQUESTED WITH RESPECT TO... (Filed With SEC on August 9, 2016)
- ***CONFIDENTIAL TREATMENT REQUESTED*** Confidential Treatment Requested by BioDelivery Sciences International, Inc. IRS Employer Identification No. 35-208985 Confidential... (Filed With SEC on October 31, 2014)
- AMENDMENT TO CLINICAL DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on May 13, 2011)
- LICENSE AND SUPPLY AGREEMENT (Filed With SEC on May 27, 2010)
- AMENDMENT TO LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on January 6, 2009)
- LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on September 10, 2007)
- LICENSE AGREEMENT between ARIUS TWO, INC. and (Filed With SEC on September 10, 2007)
- AMENDMENT TO CLINICAL DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on September 10, 2007)
- EXHIBIT A MEDA LICENSE AGREEMENT (Filed With SEC on September 10, 2007)
- AMENDMENT TO CLINICAL DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on March 16, 2007)
- BEMA LICENSE AGREEMENT (Filed With SEC on August 9, 2006)
- LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on August 9, 2006)
- CLINICAL DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on July 21, 2005)
- LICENSE AGREEMENT BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC. AND ACCENTIA, INC. (Filed With SEC on June 4, 2004)
- AMENDMENT TO LICENSE AGREEMENT BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC. AND (Filed With SEC on June 4, 2004)
